Isotechnika Pharma Announces Close of First Tranche of Private Placement of Units
October 18, 2012 09:15 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, Oct. 18, 2012 (GLOBE NEWSWIRE) -- Further to its press release of October 16, 2012, Isotechnika Pharma Inc. (TSX:ISA) announced today that it has completed the first tranche of its...
Isotechnika Pharma Announces Private Placement of Units
October 16, 2012 16:38 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, Oct. 16, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) intends to complete a non-brokered private placement of up to 21.25 million units of Isotechnika at a price of 4...
Isotechnika Reports Second Quarter 2012 Financial Results
August 14, 2012 18:35 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, Aug. 14, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) today announced financial results for the second quarter ended June 30, 2012.
The Company's financial and...
Isotechnika Pharma Receives Additional Funding From the Government of Canada for NICAM Program
July 17, 2012 08:00 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, July 17, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") today announced that it has received approval for funding from the National...
Isotechnika Pharma's Partner Lux Biosciences Completes Enrollment in Phase 3 Uveitis Study
July 09, 2012 08:11 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, July 9, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika") announced today that Lux Biosciences, Inc. ("Lux") has completed patient enrollment in its Phase 3...
Isotechnika to Present at JMP Securities Healthcare Conference
July 05, 2012 08:30 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, July 5, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced today that its CEO, Dr. Robert Foster, will present an update on the...
Isotechnika Pharma's Partner 3SBio Recieves Approval for Phase 3 Trial of Voclosporin in China
June 28, 2012 08:50 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, June 28, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced today that 3SBio Inc. (Nasdaq:SSRX), a leading China-based...
Isotechnika Reports First Quarter 2012 Financial Results
May 11, 2012 17:00 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, May 11, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) today announced financial results for the three months ended March 31, 2012.
Financial Results
For the first...
Isotechnika Pharma Announces Agreement With U.S. National Institutes of Health to Evaluate NICAM Portfolio as Anti-Viral Agents
April 11, 2012 10:35 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, April 11, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") is pleased to announce the signing of a three year Non-Clinical Evaluation...
Isotechnika Recieves Notice of ILJIN's Request for Arbitration
March 28, 2012 08:00 ET
|
Aurinia Pharmaceuticals Inc.
EDMONTON, Alberta, March 28, 2012 (GLOBE NEWSWIRE) -- Isotechnika Pharma Inc. (TSX:ISA) ("Isotechnika" or the "Company") announced today that, further to its press release of January 31, 2012, it has...